Prediction: Colgate-Palmolive Will Jump 20% This Year

Colgate-Palmolive posted Q1 2026 adjusted EPS of $0.97 versus $0.9445 consensus on revenue of $5.324 billion, up 8.4% YoY, while free cash flow rose 27.94% to $609 million. The company also raised its quarterly dividend to $0.53, marking a 63rd consecutive annual increase, and management's restructuring program targets $200-$300 million in annual pretax savings. Offsetting the positives, tariffs are pressuring margins and management cut 2026 gross margin guidance, but the stock remains framed as a defensive buy with a 12-month target of $103.17 versus $87.44 current price.

Analysis

CL is becoming a quality-defensive + self-help compounder rather than a pure bond proxy. The key second-order effect is that tariff pressure, while a near-term margin headwind, can actually widen the moat for the largest multinational staples players if smaller regional competitors lack sourcing flexibility and pricing power. If that dynamic holds, share can be taken before margin recovery fully shows up in reported numbers, creating an earnings surprise path over the next 2-3 quarters.

The market seems to be pricing CL on headline multiple alone, but the more important variable is the mix shift between organic growth and restructuring savings. A company that can keep low-single-digit organic growth while extracting $200M+ of pretax savings has a built-in offset to commodity/tariff friction; that makes forward estimates more durable than the trailing P/E suggests. The bear case is not collapse, it's a slower rerating if North America volumes stay weak and management is forced to spend savings on price investment instead of SG&A leverage.

The biggest underappreciated risk is that the defensive premium itself becomes capped by bond yields and relative rotation into higher-yield staples. If rates back up or investors rotate out of low-volatility compounds, CL can underperform even with clean fundamentals because upside is now more about multiple expansion than earnings acceleration. Conversely, a clean resolution on tariffs would likely trigger a fast rerating because the stock has already proven it can defend the low-$80s and probably has little resistance back toward the low-$90s.

Key Decisions for Investors

• Go long CL on a 3-6 month horizon, using weakness toward the low-$80s as the entry zone; risk/reward is attractive because downside appears limited to mid-single digits while a rerating toward the high-$90s is plausible if tariff headlines fade.
• Use a call spread in CL rather than outright stock for the next 6-9 months: long the 90 strike / short the 105 strike to express modest upside with defined premium at risk, since the stock likely grinds rather than gaps higher.
• Pair trade: long CL / short a smaller consumer staples or household products peer with less geographic diversification and weaker pricing flexibility; the thesis is that tariff and sourcing shocks disproportionately hit less scaled operators.
• If already long CL, sell covered calls against the position into strength over the next 1-2 earnings cycles; implied upside is respectable but near-term multiple compression risk is real if growth doesn’t inflect further.